AARDVARK THERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT May 1, 2024Investors’ Rights Agreement • January 23rd, 2025 • Aardvark Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 23rd, 2025 Company Industry JurisdictionThis Amended and Restated Investors’ Rights Agreement (this “Agreement”) is dated as of May 1, 2024, and is by and among Aardvark Therapeutics, Inc., a Delaware corporation (the “Company”), and the persons and entities listed on EXHIBIT A attached hereto (each, an “Investor” and collectively, the “Investors”).
AARDVARK THERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT May 1, 2024Investors’ Rights Agreement • October 24th, 2024 • Aardvark Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 24th, 2024 Company Industry JurisdictionThis Amended and Restated Investors’ Rights Agreement (this “Agreement”) is dated as of May 1, 2024, and is by and among Aardvark Therapeutics, Inc., a Delaware corporation (the “Company”), and the persons and entities listed on EXHIBIT A attached hereto (each, an “Investor” and collectively, the “Investors”).